GLUT4欠乏性の心臓が ischemia に反応する反応は,糖分解の重要性を強調しています
1NMR Laboratory for Physiological Chemistry, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Circulation
|June 20, 2001
まとめ
グルコーストランスポーター4型 (GLUT4) は,イシュケミア中の心臓の生存に不可欠です. その欠乏は,グルコースの利用を妨げ,重度の心臓機能不全を引き起こし,ATPの再生を減少させ,その保護的役割を強調します.
科学分野:
- 心血管生理学 心血管の生理学
- メタボリック・レギュレーション
- 分子心臓病学 分子心臓病学
背景:
- 缺血性心臓は,ATPの生産のために糖分解に依存し,生存に不可欠なグルコース利用療法を行います.
- 筋心臓缺血は,グルコーストランスポーターであるGLUT1とGLUT4の細胞膜への移動を誘発し,グルコースの吸収と糖分解を増加させます.
研究 の 目的:
- 心臓イシュケミア中のグリコリチスフルス増強におけるGLUT4の役割を調査する.
- 発血不良状態におけるGLUT4欠乏が心臓機能とエネルギー代謝に与える影響を理解する.
主な方法:
- 全球低流血性イシュケミアを患った,心臓特異的なGLUT4欠乏症 (G4H-/-) のマウスを利用した.
- 栄養状態と断食状態で,グルコースの摂取量,グリコゲン,フォスフォクレアチンのレベル,心臓機能 (シストリックとダイストリック) を分析した.
主要な成果:
- G4H-/-を摂取した心臓は,GLUT1の活性とグリコゲンの増加を示したが,発血後の回復が遅れた.
- 断食中のG4H-/-心臓は,グルコース利用率の低下,重度の不可逆的な心臓機能不全,ATPの減退の加速,および,不血症および再注射中のエネルギー再生の障害を示した.
結論:
- GLUT4は,心筋小動脈不全の際に糖分分解の増加を媒介する重要な役割を果たします.
- GLUT4は,心臓の缺血性損傷に対する重要な保護機構として機能します.
関連する概念動画
01:30Membrane Proteins
18.5K
Plasma membranes have integral transmembrane proteins involved in facilitated transport. These proteins are collectively referred to as transport proteins, and they function as either channels for the material or as carriers themselves. Channel proteins have hydrophilic domains exposed to the intracellular and extracellular fluids and a hydrophilic channel through their core that provides a hydrated opening for solutes to pass through the membrane layers. Passage through the channel allows...
18.5K
01:27Glucose Transporters
15.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
01:26Glucose Absorption Into the Small Intestine
34.0K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
34.0K
01:16Hormones Regulating Blood Glucose
7.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.5K
01:02Glucose Homeostasis: Regulation of Blood Glucose
4.3K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.3K
01:23Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K